Quick Answer
FENNEC PHARMACEUTICALS INC. reported Net Income of -$9.74 million for fiscal year 2025.
FENNEC PHARMACEUTICALS INC. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$9.74M | -2134.2% |
| 2024 | -$436.0K | +97.3% |
| 2023 | -$16.05M | +32.3% |
| 2022 | -$23.71M | -36.7% |
| 2021 | -$17.35M | +4.2% |
| 2020 | -$18.11M | -41.8% |
| 2019 | -$12.78M | -29.2% |
| 2018 | -$9.89M | -40.3% |
| 2017 | -$7.05M | -152.6% |
| 2016 | -$2.79M | -323.2% |
| 2015 | -$659.0K | +69.7% |
| 2014 | -$2.18M | -217.9% |
| 2013 | $1.84M | +135.7% |
| 2012 | -$5.16M | -210.2% |
| 2011 | $4.68M | +159.9% |
| 2010 | -$7.82M | -159.7% |
| 2009 | -$3.01M | +77.9% |
| 2008 | -$13.60M | -1.8% |
| 2007 | -$13.36M | +18.8% |
| 2006 | -$16.44M | -18.5% |
| 2005 | -$13.87M | -101.8% |
| 2004 | -$6.87M | +61.4% |
| 2003 | -$17.80M | -376.8% |
| 2002 | -$3.73M | -47.9% |
| 2001 | -$2.52M | -57.3% |
| 2000 | -$1.60M | -67.5% |
| 1999 | -$958.0K | -140.7% |
| 1998 | -$398.0K | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$638.0K | +88.9% | +79.8% |
| June 30, 2025 | -$3.15M | +43.2% | -170.6% |
| March 31, 2025 | -$1.17M | -109.1% | +79.7% |
| September 30, 2024 | -$5.74M | -207.2% | -3.3% |
| June 30, 2024 | -$5.55M | -2.0% | -143.3% |
| March 31, 2024 | $12.84M | +312.1% | +787.6% |
| September 30, 2023 | -$1.87M | +76.9% | +65.7% |
| June 30, 2023 | -$5.44M | -7.3% | +10.0% |
- FENNEC PHARMACEUTICALS INC. showed a decrease of -2134.2% in Net Income compared to the prior fiscal year.
- Over the 1998–2025 period, FENNEC PHARMACEUTICALS INC.’s net income has declined by 2347.5% (from -$398.0 thousand to -$9.74 million).
- The most recent figure is from FENNEC PHARMACEUTICALS INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: